688163 赛伦生物
已收盘 08-03 15:00:00
资讯
新帖
简况
赛伦生物跌4.75% 2022年上市超募3.85亿方正证券保荐
中金财经 · 08-03 16:25
赛伦生物跌4.75% 2022年上市超募3.85亿方正证券保荐
赛伦生物跌9.01% 2022年上市超募3.85亿方正证券保荐
中金财经 · 07-30
赛伦生物跌9.01% 2022年上市超募3.85亿方正证券保荐
7月20日赛伦生物跌7.47%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 07-20
7月20日赛伦生物跌7.47%，中信保诚多策略混合(LOF)A基金重仓该股
7月17日赛伦生物跌15.52%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 07-17
7月17日赛伦生物跌15.52%，中信保诚多策略混合(LOF)A基金重仓该股
7月8日赛伦生物跌13.11%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 07-08
7月8日赛伦生物跌13.11%，中信保诚多策略混合(LOF)A基金重仓该股
7月7日赛伦生物跌6.36%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 07-07
7月7日赛伦生物跌6.36%，中信保诚多策略混合(LOF)A基金重仓该股
6月17日赛伦生物涨7.61%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 06-17
6月17日赛伦生物涨7.61%，中信保诚多策略混合(LOF)A基金重仓该股
每周股票复盘：赛伦生物（688163）因股价涨幅达15%登龙虎榜
证券之星 · 06-14
每周股票复盘：赛伦生物（688163）因股价涨幅达15%登龙虎榜
每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%
证券之星 · 05-24
每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%
赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%
证券之星 · 05-19
赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%
每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过
证券之星 · 05-17
每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过
赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%
证券之星 · 05-15
赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%
赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%
证券之星 · 05-13
赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%
5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 05-13
5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股
赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%
证券之星 · 05-08
赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%
赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书
智通财经 · 05-07
赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书
赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%
证券之星 · 05-06
赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%
每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会
证券之星 · 05-02
每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会
4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股
证券之星 · 04-27
4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股
赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%
证券之星 · 04-25
赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%
公司概况
公司名称：
上海赛伦生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-11
主营业务：
上海赛伦生物技术股份有限公司的主营业务是抗血清抗毒素等的生产、研发和销售。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。
发行价格：
33.03
{"stockData":{"symbol":"688163","market":"SH","secType":"STK","nameCN":"赛伦生物","latestPrice":27.45,"timestamp":1785740400000,"preClose":28.82,"halted":0,"volume":1743958,"delay":0,"changeRate":-0.0475,"floatShares":108000000,"shares":108000000,"eps":0.4491,"marketStatus":"已收盘","change":-1.37,"latestTime":"08-03 15:00:00","open":28.63,"high":28.9,"low":27.39,"amount":48606300,"amplitude":0.0524,"askPrice":27.45,"askSize":19,"bidPrice":27.42,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.4491,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785807000000},"marketStatusCode":5,"adr":0,"adjPreClose":28.82,"symbolType":"stock_kcb","openAndCloseTimeList":[[1785720600000,1785727800000],[1785733200000,1785740400000]],"highLimit":31.7,"lowLimit":25.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108220000,"isCdr":false,"pbRate":2.67,"roa":"--","peRate":61.122244,"roe":"0.05%","epsLYR":0.48,"committee":-0.731765,"marketValue":2971000000,"turnoverRate":0.0161,"status":1,"afterMarket":{"amount":0,"volume":0,"close":27.45,"buyVolume":0,"sellVolume":0,"time":1785742437746,"indexStatus":"已收盘 08-03 15:30:00","preClose":28.82},"floatMarketCap":2971000000},"requestUrl":"/m/hq/s/688163/wiki","defaultTab":"wiki","newsList":[{"id":"2656321708","title":"赛伦生物跌4.75% 2022年上市超募3.85亿方正证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2656321708","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2656321708?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:25","pubTimestamp":1785745501,"startTime":"0","endTime":"0","summary":"中国经济网北京8月3日讯 赛伦生物 今日收报27.45元，跌幅4.75%。 赛伦生物于2022年3月11日在上交所科创板上市，发行数量为2,706.00万股，发行价格为33.03元/股，保荐机构为方正证券承销保荐有限责任公司，保荐代表人为代礼正、毛秋亮。 赛伦生物上市首日盘中最高价报62.99元，为该股上市以来最高价。 赛伦生物首次公开发行股票发行费用总额为10,886.82万元，其中，保荐及承销费用为9,000.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260803/32324635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601901","BK0028","BK0012","BK0122","BK0183","BK0276","BK0239","IPOS","BK0188","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655822300","title":"赛伦生物跌9.01% 2022年上市超募3.85亿方正证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2655822300","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2655822300?lang=zh_cn&edition=full","pubTime":"2026-07-30 16:52","pubTimestamp":1785401524,"startTime":"0","endTime":"0","summary":"中国经济网北京7月30日讯 赛伦生物 今日收报25.86元，跌幅9.01%。 赛伦生物于2022年3月11日在上交所科创板上市，发行数量为2,706.00万股，发行价格为33.03元/股，保荐机构为方正证券承销保荐有限责任公司，保荐代表人为代礼正、毛秋亮。 赛伦生物上市首日盘中最高价报62.99元，为该股上市以来最高价。 赛伦生物首次公开发行股票发行费用总额为10,886.82万元，其中，保荐及承销费用为9,000.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260730/32321882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","601901","BK0012","BK0028","BK0183","BK0239","IPOS","BK0188","688163","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652968862","title":"7月20日赛伦生物跌7.47%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652968862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652968862?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:26","pubTimestamp":1784535970,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日赛伦生物跌7.47%创60日新低，收盘报30.21元，换手率2.87%，成交量3.1万手，成交额9578.99万元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为6.81亿元，最新净值2.0388，较上一交易日下跌3.74%，近一年下跌0.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0251144936.SGD","LU1880383366.USD","BK1184","160921","688163","02378","BK0239","LU0048597586.USD","LU1015430645.USD","LU0211331839.USD","LU0575583348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652405144","title":"7月17日赛伦生物跌15.52%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652405144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652405144?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:23","pubTimestamp":1784276587,"startTime":"0","endTime":"0","summary":"王颖在任的基金产品包括:中信保诚新锐混合A，管理时间为2020年1月8日至今，期间收益率为49.03%；中信保诚中证500指数增强A，管理时间为2024年6月21日至今，期间收益率为63.24%；中信保诚瑞丰6个月混合A，管理时间为2025年2月25日至今，期间收益率为0.69%；中信保诚多策略混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0575583348.USD","688163","LU0211331839.USD","160921","BK0239","LU0251144936.SGD","LU0048597586.USD","LU1880383366.USD","LU1015430645.USD","02378","BK1184"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969259","title":"7月8日赛伦生物跌13.11%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649969259?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:29","pubTimestamp":1783499386,"startTime":"0","endTime":"0","summary":"王颖在任的基金产品包括:中信保诚新锐混合A，管理时间为2020年1月8日至今，期间收益率为50.4%；中信保诚中证500指数增强A，管理时间为2024年6月21日至今，期间收益率为72.31%；中信保诚瑞丰6个月混合A，管理时间为2025年2月25日至今，期间收益率为0.95%；中信保诚多策略混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800029190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0575583348.USD","LU1880383366.USD","688163","LU0211331839.USD","LU0251144936.SGD","BK0239","02378","LU1015430645.USD","LU0048597586.USD","160921","BK1184"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649198881","title":"7月7日赛伦生物跌6.36%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649198881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649198881?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:29","pubTimestamp":1783412947,"startTime":"0","endTime":"0","summary":"证券之星消息，7月7日赛伦生物跌6.36%，收盘报44.01元，换手率1.59%，成交量1.73万手，成交额7767.77万元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.1373，较上一交易日下跌0.9%，近一年上涨6.97%。该公募基金现任基金经理为王颖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700027387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1184","LU1880383366.USD","LU1015430645.USD","LU0251144936.SGD","160921","LU0048597586.USD","688163","LU0211331839.USD","BK0239","02378","LU0575583348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644711480","title":"6月17日赛伦生物涨7.61%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644711480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644711480?lang=zh_cn&edition=full","pubTime":"2026-06-17 16:33","pubTimestamp":1781685200,"startTime":"0","endTime":"0","summary":"王颖在任的基金产品包括:中信保诚新锐混合A，管理时间为2020年1月8日至今，期间收益率为51.32%；中信保诚中证500指数增强A，管理时间为2024年6月21日至今，期间收益率为67.98%；中信保诚瑞丰6个月混合A，管理时间为2025年2月25日至今，期间收益率为1.3%；中信保诚多策略混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700027903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0575583348.USD","LU1880383366.USD","LU0048597586.USD","160921","LU0251144936.SGD","02378","LU1015430645.USD","688163","BK1184","LU0211331839.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643934217","title":"每周股票复盘：赛伦生物（688163）因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2643934217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643934217?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:22","pubTimestamp":1781371332,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，赛伦生物报收于45.04元，较上周的36.52元上涨23.33%。本周，赛伦生物6月12日盘中最高价报45.04元，股价触及近一年最高点。6月8日盘中最低价报33.3元。本周共计1次涨停收盘，无跌停收盘情况。赛伦生物当前最新总市值48.74亿元，在生物制品板块市值排名40/51，在两市A股市值排名3326/5206。本周关注点来自交易信息汇总：赛伦生物因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637754063","title":"每周股票复盘：赛伦生物（688163）2025年扣非净利增50.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637754063","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637754063?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:08","pubTimestamp":1779566893,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，赛伦生物报收于39.58元，较上周的39.0元上涨1.49%。本周关注点来自业绩披露要点：2025年扣非后净利润同比增长50.91%。公司公告汇总方正证券承销保荐有限责任公司发布了关于上海赛伦生物技术股份有限公司2025年度持续督导跟踪报告。2025年度，公司营业收入1.96亿元，净利润5178.74万元，扣非后净利润同比增长50.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636783772","title":"赛伦生物（688163）披露2025年度持续督导跟踪报告，5月19日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636783772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636783772?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:19","pubTimestamp":1779185956,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，赛伦生物报收于39.8元，较前一交易日下跌0.82%，最新总市值为43.07亿元。近日，方正证券承销保荐有限责任公司发布了关于上海赛伦生物技术股份有限公司2025年度持续督导跟踪报告。报告指出，赛伦生物在持续督导期间依法合规运作，未发生需保荐机构公开发表声明的违法违规事项，亦无重大违规行为。2025年度，公司营业收入1.96亿元，净利润5178.74万元，扣非后净利润同比增长50.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900035294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636621810","title":"每周股票复盘：赛伦生物（688163）2025年年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2636621810","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636621810?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:37","pubTimestamp":1778963828,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，赛伦生物报收于39.0元，较上周的36.94元上涨5.58%。本周关注点来自公司公告汇总：赛伦生物2025年年度股东会审议通过利润分配方案、续聘审计机构等多项议案。来自公司公告汇总：上海市锦天城律师事务所确认赛伦生物2025年年度股东会召集、表决程序合法有效。上海市锦天城律师事务所就上海赛伦生物技术股份有限公司2025年年度股东会的召集和召开程序、出席会议人员资格、召集人资格、表决程序及表决结果出具法律意见书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035515","title":"赛伦生物（688163）披露2025年年度股东会决议公告，5月15日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035515","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635035515?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:54","pubTimestamp":1778856856,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，赛伦生物报收于39.0元，较前一交易日下跌0.94%，最新总市值为42.21亿元。该股当日开盘40.16元，最高40.61元，最低38.35元，成交额达9338.85万元，换手率为2.21%。近日，赛伦生物发布《2025年年度股东会决议公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635001182","title":"赛伦生物（688163）披露首次公开发行持续督导保荐总结报告书，5月13日股价下跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635001182","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635001182?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:56","pubTimestamp":1778666201,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，赛伦生物报收于37.81元，较前一交易日下跌5.43%，最新总市值为40.92亿元。该股当日开盘39.81元，最高39.81元，最低36.9元，成交额达1.52亿元，换手率为3.72%。公告显示，作为赛伦生物首次公开发行股票并在科创板上市的保荐机构，方正证券的持续督导期自2022年3月11日至2025年12月31日届满。实际控制人范志和曾被留置并立案调查，后已于2023年10月29日解除留置。截至2025年12月31日，持续督导期限已满，保荐机构完成保荐总结工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635201756","title":"5月13日赛伦生物跌5.43%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635201756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635201756?lang=zh_cn&edition=full","pubTime":"2026-05-13 16:31","pubTimestamp":1778661073,"startTime":"0","endTime":"0","summary":"证券之星消息，5月13日赛伦生物跌5.43%，收盘报37.81元，换手率3.72%，成交量4.03万手，成交额1.52亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.5523，较上一交易日下跌1.39%，近一年上涨36.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300029492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0251144936.SGD","LU1015430645.USD","BK1184","LU0211331839.USD","LU0048597586.USD","LU0575583348.USD","160921","LU1880383366.USD","02378","BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633392814","title":"赛伦生物（688163）披露抗蜂毒血清获临床试验批准通知书，5月8日股价上涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633392814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633392814?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:27","pubTimestamp":1778232463,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，赛伦生物报收于36.94元，较前一交易日上涨2.61%，最新总市值为39.98亿元。赛伦生物于近日披露《自愿披露关于抗蜂毒血清获得药物临床试验批准通知书的公告》。公告显示，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意其自主研发的抗蜂毒血清开展临床试验。截至目前，国内外尚无同类抗蜂毒血清产品获批上市。该产品需完成后续临床试验并经审批后方可生产上市，短期内对公司业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633198191","title":"赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633198191","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633198191?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:46","pubTimestamp":1778143577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意公司申报的抗蜂毒血清开展临床试验。抗蜂毒血清是公司自主研发、拥有独立知识产权的治疗用生物制品1类创新药，含有特异性抗体，具有中和蜂毒的作用。公司自主研发的抗蜂毒血清作为一种含有多克隆抗体的血清，作用机制明确，能够特异性中和蜂毒，从而减轻或消除其对人体造成的损害。与现有的急救措施和对症治疗手段相比，抗蜂毒血清能够从源头上中和蜂毒抗原，阻止毒素与靶细胞结合，从治疗机理上具有显著的治疗优势，有望为蜂蜇伤患者提供更加有效的治疗手段、填补对抗蜂毒毒素药物的空白。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"赛伦生物(688163.SH)：抗蜂毒血清获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633113425","title":"赛伦生物（688163）披露2025年年度股东会会议资料，5月6日股价上涨0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633113425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633113425?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:46","pubTimestamp":1778078777,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，赛伦生物报收于35.35元，较前一交易日上涨0.43%，最新总市值为38.26亿元。该股当日开盘35.9元，最高36.56元，最低34.81元，成交额达7862.3万元，换手率为2.03%。近日，赛伦生物发布《2025年年度股东会会议资料》。公告显示，2025年公司实现营业收入19,620.59万元，同比增长0.66%；归属于上市公司股东的净利润5,178.74万元，同比增长16.93%。同时提请授权董事会进行2026年中期分红，并拟使用部分超募资金增加募投项目投资及补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600040132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625403","title":"每周股票复盘：赛伦生物（688163）将参加2026年5月13日业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625403","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625403?lang=zh_cn&edition=full","pubTime":"2026-05-02 07:18","pubTimestamp":1777677493,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，赛伦生物报收于35.2元，较上周的37.0元下跌4.86%。本周，赛伦生物4月30日盘中最高价报36.78元。本周关注点公司公告汇总：赛伦生物将参加2026年5月13日举行的生物制品行业集体业绩说明会。投资者可于2026年5月6日至5月12日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630365775","title":"4月27日赛伦生物跌5.22%，中信保诚多策略混合(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630365775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630365775?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:28","pubTimestamp":1777278528,"startTime":"0","endTime":"0","summary":"证券之星消息，4月27日赛伦生物跌5.22%，收盘报35.07元，换手率5.09%，成交量5.51万手，成交额1.9亿元。重仓赛伦生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中信保诚基金的中信保诚多策略混合A。中信保诚多策略混合A目前规模为10.84亿元，最新净值2.443，较上一交易日上涨0.94%，近一年上涨36.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0251144936.SGD","LU1880383366.USD","688163","160921","BK1184","LU0048597586.USD","LU0575583348.USD","02378","LU1015430645.USD","LU0211331839.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870550","title":"赛伦生物(688163)3月31日股东户数0.73万户，较上期增加8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870550","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870550?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:06","pubTimestamp":1777107998,"startTime":"0","endTime":"0","summary":"证券之星消息，近日赛伦生物披露，截至2026年3月31日公司股东户数为7269.0户，较12月31日增加595.0户，增幅为8.92%。在生物制品行业个股中，赛伦生物股东户数低于行业平均水平，截至3月31日，生物制品行业平均股东户数为3.6万户。从股价来看，2025年12月31日至2026年3月31日，赛伦生物区间涨幅为27.1%，在此期间股东户数增加595.0户，增幅为8.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785776597905,"stockEarnings":[{"period":"1week","weight":-0.1041},{"period":"1month","weight":-0.4348},{"period":"3month","weight":-0.2146},{"period":"6month","weight":0.1041},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.2698}],"compareEarnings":[{"period":"1week","weight":-0.0126},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.0736},{"period":"6month","weight":-0.0713},{"period":"1year","weight":0.0701},{"period":"ytd","weight":-0.0401}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海赛伦生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7269人(较上一季度增加8.92%)","perCapita":"14887股","listingDate":"2022-03-11","address":"上海市青浦区华青路1288号","registeredCapital":"10822万元","survey":" 上海赛伦生物技术股份有限公司的主营业务是抗血清抗毒素等的生产、研发和销售。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。","listedPrice":33.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛伦生物,688163,赛伦生物股票,赛伦生物股票老虎,赛伦生物股票老虎国际,赛伦生物行情,赛伦生物股票行情,赛伦生物股价,赛伦生物股市,赛伦生物股票价格,赛伦生物股票交易,赛伦生物股票购买,赛伦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}